Pro Share Advisors LLC Mersana Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

$36.7 Billion
Q1 2024

A detailed history of Pro Share Advisors LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 19,919 shares of MRSN stock, worth $37,447. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,919

Previous 18,350 8.55%

Holding current value

$37,447

Previous $42,000 111.9%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$2.16 - $5.94 $3,389 - $9,319	1,569 Added 8.55%	19,919 $89,000
Q4 2023 Feb 14, 2024	SELL	$1.11 - $2.34 $3,552 - $7,488	-3,200 Reduced 14.85%	18,350 $42,000
Q3 2023 Nov 13, 2023	BUY	$1.06 - $3.91 $1,164 - $4,297	1,099 Added 5.37%	21,550 $27,000
Q2 2023 Aug 10, 2023	BUY	$3.08 - $9.55 $6,372 - $19,758	2,069 Added 11.26%	20,451 $67,000
Q1 2023 May 11, 2023	SELL	$4.0 - $7.02 $7,116 - $12,488	-1,779 Reduced 8.82%	18,382 $75,000

Q4 2022 Feb 02, 2023	BUY	$5.65 - $7.86 $11,588 - $16,120	2,051 Added 11.33%	20,161 $118,000
Q3 2022 Nov 04, 2022	BUY	$4.63 - $8.0 $3,291 - $5,688	711 Added 4.09%	18,110 $122,000
Q2 2022 Aug 01, 2022	SELL	$2.84 - $5.0 $13,203 - $23,245	-4,649 Reduced 21.09%	17,399 $80,000
Q1 2022 May 10, 2022	SELL	$3.74 - $6.63 $13,909 - $24,656	-3,719 Reduced 14.43%	22,048 $88,000
Q4 2021 Feb 08, 2022	BUY	$5.48 - $9.86 $6,948 - $12,502	1,268 Added 5.18%	25,767 $161,000
Q3 2021 Nov 12, 2021	SELL	$8.56 - $14.47 $50,221 - $84,895	-5,867 Reduced 19.32%	24,499 $231,000
Q2 2021 Aug 13, 2021	BUY	$13.28 - $18.07 $87,475 - $119,027	6,587 Added 27.7%	30,366 $412,000
Q1 2021 May 14, 2021	BUY	$15.31 - $26.52 $21,663 - $37,525	1,415 Added 6.33%	23,779 $385,000
Q4 2020 Feb 09, 2021	BUY	$16.84 - $27.59 $376,609 - $617,022	22,364 New	22,364 $595,000
Q4 2018 Feb 14, 2019	SELL	$3.45 - $9.72 $37,887 - $106,745	-10,982 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$10.0 - $19.02 $2,820 - $5,363	-282 Reduced 2.5%	10,982 $110,000
Q2 2018 Aug 13, 2018	SELL	$14.2 - $22.68 $9,741 - $15,558	-686 Reduced 5.74%	11,264 $201,000
Q1 2018 May 14, 2018	SELL	$13.56 - $18.48 $14,346 - $19,551	-1,058 Reduced 8.13%	11,950 $188,000
Q4 2017 Feb 14, 2018	BUY	$14.95 - $19.9 $194,469 - $258,859	13,008	13,008 $214,000

Others Institutions Holding MRSN

# of Institutions

128

Shares Held

118M

Call Options Held

68.1K

Put Options Held

140K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $183M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Mersana Therapeutics, Inc. Transaction History